The subjects were 21 patients who underwent allogeneic SCT from June 2001 to February 2005 in our institutions. One of the cases developed TMA/TTP after SCT, but the other 20 cases did not. All ...
Post-transplantation thrombotic microangiopathy (TMA), first described nearly 30 years ago, 1 remains an infrequent, but frustrating complication of SCT. The etiologies of this syndrome are thought to ...
Pseudo-thrombotic microangiopathy (pseudo-TMA) is relatively easy to treat, but it is also easy to mistake for a much more serious condition, thrombotic thrombocytopenic purpura (TTP). In a new report ...
Despite this advance in the treatment of TTP and resultant improvements in survival, significant gains in the understanding of TTP pathophysiology were not made until 2001 with the identification of ...
SEATTLE, May 06, 2025--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the Biologics ...
The top 5 articles about rare blood featured information on pseudo–thrombotic thrombocytopenic purpura (TTP), immune TTP, and hemophilia. The top read news in rare blood in 2023 included research on ...
Thrombotic microangiopathy further decreases patient and renal survival in patients with SLE. Patients with systemic lupus erythematosus (SLE) with thrombotic microangiopathy (TMA) have lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback